Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aimmune Therap (NQ: AIMT )

34.49 USD UNCHANGED
Last Price Updated: 7:11 PM EDT, Oct 12, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Aimmune Therap

< Previous 1 2 3 4 5 6 7 Next >
Aimmune Presents New Clinical Data From Pooled Safety Analysis in Patients Treated With PALFORZIA® for up to ~3.5 Years
Aimmune Therapeutics, a Nestlé Health Science company developing and commercializing treatments for potentially life-threatening food allergies, today announced new clinical data from a pooled analysis... 
From Business Wire News Releases
Aimmune Therapeutics, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit: Portnoy Law Firm
From GlobeNewswire News Releases
Health Beverage Market Demand and Growth Analysis 2020 - Prada, Burberry, Chanel, Coach, HERMS
Harrisburg, NC -- (SBWIRE) -- 10/30/2020 -- The Health Beverage Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from... 
From SBWire - Latest Press Releases
Monteverde & Associates PC Files Class Action Lawsuit On Behalf Of Shareholders Of Aimmune Therapeutics, Inc. In The Northern District Of California
Notice is hereby given that Monteverde & Associates PC has filed a class action lawsuit in the United States District Court for the Northern District of California, Case No. 4:20-cv-06733-YGR, on... 
From PR Newswire
Nestlé announces results of tender offer for Aimmune Therapeutics, Inc.
Société des Produits Nestlé S.A. ("Nestlé") today announced the results of the tender offer by its wholly-owned subsidiary, SPN MergerSub, Inc. ("Purchaser"), to purchase all of the outstanding shares... 
From PR Newswire
Life-Saving Advancements, Treatments Delivered by Companies Invested in Innovation
From InvestorBrandNetwork
Life-Saving Advancements, Treatments Delivered by Companies Invested in Innovation
NetworkNewsWire Editorial Coverage 
From PR Newswire
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of AIMT, BMCH, BYFC, and CGIX Mergers
From GlobeNewswire News Releases
Longitude Capital Raises $585 Million Fund to Invest in Transformative Healthcare Companies
From GlobeNewswire News Releases
MERGER INVESTIGATION ALERT: Halper Sadeh LLP Reminds Investors About Its Ongoing Investigations; Shareholders are Encouraged to Contact the Firm – MNTA, VRTU, AIMT, MXIM
From ACCESSWIRE
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Aimmune Therapeutics, Inc. - AIMT
Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating Aimmune... 
From PR Newswire
ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm
Halper Sadeh LLP, a global investor rights law firm, is investigating: 
From PR Newswire
Lifshitz Law Firm, P.C. Announces Investigation of Aimmune Therapeutics, Inc., (NASDAQ:AIMT), Akcea Therapeutics, Inc., (NASDAQ:AKCA), BMC Stock Holdings, Inc., (NASDAQ:BMCH), and Cancer Genetics, Inc
From GlobeNewswire News Releases
Nestlé commences tender offer for Aimmune Therapeutics, Inc.
Société des Produits Nestlé S.A. ("Nestlé") announced that its wholly-owned subsidiary, SPN Merger Sub, Inc. ("Purchaser"), is commencing today a cash tender offer to purchase all of the outstanding... 
From PR Newswire
ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm – AIMT, AKCA, PTI
From ACCESSWIRE
INVESTIGATION ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm – RST, CBMG, AIMT, AKCA
Halper Sadeh LLP, a global investor rights law firm, is investigating: 
From Business Wire News Releases
SHAREHOLDER ALERT: WeissLaw LLP Reminds AKCA and AIMT Shareholders About Its Ongoing Investigations
From PR Newswire
Lifshitz Law Firm, P.C. Announces Investigation of Aimmune Therapeutics, Inc., Akcea Therapeutics, Inc., BMC Stock Holdings, Inc., Builders FirstSource, Inc., Broadway Financial Corporation, Cancer G
From PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm – MNTA, BMCH, RST, AIMT
From ACCESSWIRE
Kaskela Law LLC Announces Stockholder Investigation of Aimmune Therapeutics, Inc. (AIMT) and Encourages Investors to Contact the Firm
Kaskela Law LLC announces that it is investigating Aimmune Therapeutics, Inc. ("Aimmune") (NASDAQ: AIMT) on behalf of the company's shareholders. 
From PR Newswire
AIMMUNE INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of  Aimmune Therapeutics Inc. - AIMT
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of  Aimmune Therapeutics Inc. (NasdaqGS: AIMT)... 
From Business Wire News Releases
Moore Kuehn Encourages MNTA, AIMT, ONDK, and OTEL Investors to Contact Law Firm
From GlobeNewswire News Releases
INVESTIGATION ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm - RST, CBMG, AIMT, MR
Halper Sadeh LLP, a global investor rights law firm, continues to investigate: 
From PR Newswire
Bullish stock with Highest Volume: $AIMT $PCG $UTSI
Tags The Market Signal
From The Market Signal
SHAREHOLDER ALERT: WeissLaw LLP Investigates Aimmune Therapeutics, Inc.
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Aimmune Therapeutics, Inc. ("AIMT" or the "Company") (NASDAQ: AIMT) in... 
From PR Newswire
AIMMUNE THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of AIMT and Encourages Investors to Contact the Firm
From GlobeNewswire News Releases
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Aimmune Therapeutics, Inc.
Rowley Law PLLC is investigating potential securities law violations by Aimmune Therapeutics, Inc. (NASDAQ: AIMT) and its board of directors concerning the proposed acquisition of the company by Nestlé... 
From Business Wire News Releases
Thinking about buying stock in Aimmune Therapeutics, FSD Pharma, Amarin Corp, Trevena Inc, or American Airlines?
InvestorsObserver issues critical PriceWatch Alerts for AIMT, HUGE, AMRN, TRVN, and AAL. 
From PR Newswire
(AIMT) Alert: Johnson Fistel Investigates Proposed Sale of Aimmune Therapeutics; Is $34.50 a Fair Price?
Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Aimmune Therapeutics, Inc. ("Aimmune" or the "Company") (NASDAQ: AIMT) breached their... 
From PR Newswire
Aimmune Therapeutics Enters Definitive Agreement with Sociétés des Produits Nestlé S.A., Part of Nestlé Health Science
Aimmune Therapeutics Inc. (Nasdaq: AIMT), a biopharmaceutical company developing and commercializing treatments for potentially life-threatening food allergies, today announced that it has entered into... 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
X